The emerging approach of this peptide represents a exciting breakthrough in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide789697.p2blogs.com/40401412/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment